 13. Subjects undergoing treatment or received treatment within 8 weeks of Visit 1Day 1 baseline and within 2cm of the selected area or planned during anytime in the study of: 5-FU, imiquimod, diclofenac, photodynamic therapy used in combination with photosensitizing cream. 